Free Trial
NASDAQ:OPTH

Optimi Health (OPTH) Stock Price, News & Analysis

$3.16 -0.34 (-9.71%)
As of 10/14/2026 03:59 PM Eastern

About Optimi Health Stock (NASDAQ:OPTH)

Advanced

Key Stats

Today's Range
$3.04
▼
$3.54
50-Day Range
$3.16
▼
$5.15
52-Week Range
$3.04
▼
$6.40
Volume
54,634 shs
Average Volume
37,116 shs
Market Capitalization
$18.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Optimi Health Corp. is a Canadian life sciences company focused on the development and production of psychedelic and functional mushroom products. The company’s work centers on naturally sourced compounds, including psilocybin, for potential applications in mental health and wellness.

Optimi operates a production and research facility in Princeton, British Columbia, where it develops mushroom-based formulations and related products. Its activities have included the cultivation, extraction, formulation and packaging of products intended for clinical research, therapeutic development and consumer wellness markets, subject to applicable regulatory requirements.

The company serves customers and research partners primarily from Canada and is also focused on opportunities in international markets as regulations governing psychedelic medicines and mushroom-derived products evolve. Optimi Health is led by Chief Executive Officer Bill Ciprick, who has been associated with the company since its early development.

AI Generated. May Contain Errors.

Receive OPTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OPTH Stock News Headlines

Optimi Health to Present at the ThinkEquity Conference
Optimi Health to Present at the ThinkEquity Conference
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
Optimi Health Appoints Melanie Pump to Board of Directors
See More Headlines

OPTH Stock Analysis - Frequently Asked Questions

Optimi Health's stock was trading at $6.08 on May 20, 2026. Since then, OPTH stock has decreased by 48.0% and is now trading at $3.16.

Optimi Health shares reverse split before market open on Wednesday, May 20th 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 19th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Optimi Health (OPTH) raised $15 million in an initial public offering (IPO) on Wednesday, May 20th 2026. The company issued 2,400,000 shares at $6.25 per share. Joseph Gunnar & Co. served as the underwriter for the IPO.

Optimi Health's lock-up period expires on Monday, November 16th. Optimi Health had issued 2,400,000 shares in its public offering on May 20th. The total size of the offering was $15,000,000 based on an initial share price of $6.25. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Shares of OPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/15/2026
The ThinkEquity Conference
10/15/2026
Fiscal Year End
9/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:OPTH
CIK
2027329
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
0.06
Quick Ratio
0.03

Sales & Book Value

Annual Sales
$310 thousand
Price / Sales
58.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
5,730,000
Free Float
N/A
Market Cap
$18.11 million
Optionable
N/A
Beta
N/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:OPTH) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners